Prospects for the sulfur-containing amino acids medicines usage for trimethylamine-N-oxide biosynthesis modulation in humans
The aim: to identify prospects for the sulfur-containing amino acids medicines usage for trimethylamine oxide (TMAO) biosynthesis modulation in humans. Intestinal microbiome and its metabolic products are currently widely discussed as a new therapeutic target for the treatment of cardiovascular,...
Main Authors: | I. O. Melnychuk, M. L. Sharaieva, V. N. Kramarova, V. H. Lyzohub |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2023-01-01
|
Series: | Patologìâ |
Subjects: | |
Online Access: | http://pat.zsmu.edu.ua/article/view/263564/268981 |
Similar Items
-
Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01) -
Trimethylamine-N-oxide: a potential biomarker and therapeutic target in ischemic stroke
by: Yuan Liu, et al.
Published: (2023-04-01) -
Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults
by: Marc Ferrell, et al.
Published: (2021-11-01) -
<i>Bifidobacterium breve</i> and <i>Bifidobacterium longum</i> Attenuate Choline-Induced Plasma Trimethylamine N-Oxide Production by Modulating Gut Microbiota in Mice
by: Qianqian Wang, et al.
Published: (2022-03-01) -
Quantification of Trimethylamine-<i>N</i>-Oxide and Trimethylamine in Fish Oils for Human Consumption
by: Dominik Dörfel, et al.
Published: (2024-03-01)